Eye Health News and Research

Latest Eye Health News and Research

CogniFit releases new cognitive training application

CogniFit, a leading developer of online brain training and cognitive programs announces the release of a new cognitive training application "Tennis Focus" to its online platform. The tasks of the Tennis Focus application are developed in 3D, train a large variety of cognitive skills such as focus, visual perception, visual scanning and eye-hand coordination.

8 Oct 2012

Researchers perfect map of vision in the brain based upon brain structure

Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.

6 Oct 2012

Government investment in eye examinations may boost the economy

Governments could add thousands of millions of dollars to the global economy simply by investing in eye examinations and the provision of glasses for some 703 million people who need them, according to a study published this month in the Bulletin of the World Health Organization.

6 Oct 2012

Daily lenses vary in ocular response, adverse effects

Narafilcon A contact lenses worn daily do not perform clinically as well as etafilcon A and senofilcon A lenses worn on the same schedule, show study results involving 120 contact lens wearers.

5 Oct 2012

Cognitively-based compassion training can boost empathic accuracy

A compassion-based meditation program can significantly improve a person's ability to read the facial expressions of others, finds a study published by Social Cognitive and Affective Neuroscience.

5 Oct 2012

Patients with eye diseases can benefit from ArtCornea

Blindness is often caused by corneal diseases. The established treatment is a corneal transplant, but in many cases this is not possible and donor corneas are often hard to come by. In the future, an artificial cornea could make up for this deficiency and save the vision of those affected.

5 Oct 2012

Heavy caffeinated coffee consumption may increase risk of exfoliation glaucoma

A new study suggests caffeinated coffee drinkers should limit their intake to reduce their chances of developing vision loss or blindness. According to a scientific paper in Investigative Ophthalmology & Visual Science, heavy caffeinated coffee consumption is associated with an increased risk of developing exfoliation glaucoma, the leading cause of secondary glaucoma worldwide.

4 Oct 2012

Esthesiometry may help vision professionals in evaluating dry eyes

A simple test of eyelid sensitivity may help vision professionals in evaluating one of the most common eye-related symptoms: dry eyes. A new study linking increased eyelid sensitivity to decreased function of the eyelid margins is presented in the article - " Lid Margins: Sensitivity, Staining, Meibomian Gland Dysfunction, and Symptoms", appearing in the October issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

4 Oct 2012

New contact lenses can cure nearsightedness, slow progression rates in children

Nearsightedness, or myopia, affects more than 40 percent of people in the U.S. and up to 90 percent of children in some parts of Asia. The problem begins in childhood and often progresses with age.

3 Oct 2012

Ranibizumab injections keep those with AMD driving longer

The advanced neovascular, or “wet,” form of age-related macular degeneration (AMD), left untreated, is the most common cause of vision loss among the elderly and a leading reason for their loss of driving privileges. But results of a new study, published in the online version of the journal Ophthalmology, suggest that monthly injections of ranibizumab improve eye chart test results required for a driver’s license, build driver confidence and keep those with AMD driving longer.

3 Oct 2012

Chloroquine begins to work against malaria

Malaria-drug monitoring over the past 30 years has shown that malaria parasites develop resistance to medicine, and the first signs of resistance to the newest drugs have just been observed. At the same time, resistance monitoring at the University of Copenhagen shows that the previously efficacious drug chloroquine is once again beginning to work against malaria. In time that will ensure cheaper treatment for the world's poor.

3 Oct 2012

FDA panel recommends U.S. approval for Second Sight’s Argus II bionic eye

On Friday September 28th, a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel unanimously voted 19-0 that the probable benefit of the Argus II Retinal Prosthesis System outweighs the risks to health, an important step toward the FDA market approval of this product manufactured by Second Sight Medical Products, Inc.

3 Oct 2012